Introduction
Evidence implicating Chlamydia trachomatis as the agent responsible for a large number of inflammatory processes affecting neonates, infants, and adults of both sexes has accumulated in published reports. At present, the most accepted means of diagnosing infections caused by C trachomatis is the isolation of the organism in cycloheximide treated McCoy cells, though several methods independent of culture have recently been developed. ' 
Discussion
In this limited case controlled study using the ElectroNucleonics test for serum IgG antibodies against C trachomatis, most of the patients studied had apparently been exposed to C trachomatis previously, as 58/60 (97%) had titres of 1/8 or more. Serum samples containing specific antibody at a titre of 1/128 or more were taken from more case patients than controls, though no signficiant difference between the geometric mean titres was found. In this setting, therefore, a single antibody titre estimation has little value on an individual basis because of the low sensitivity (67%) using the interpretation offered by the manufacturer. The specificity and positive and negative predictive values of the antibody assay were also each 67%, and a titre of 1/128 or more was therefore difficult to relate to isolation or antigen detection results. We cannot, however, rule out the possibility that C trachomatis infection may have occurred at another anatomical site. It is also possible that patients with "false positive" antibody tests (titre 1/128 or more with negative isolation or Chlamydiazyme results) may have eliminated the organism from the cervix naturally before sample collection. Also, isolation of the organism in cycloheximide treated McCoy cells may not be a sensitive enough procedure to detect some asymptomatic infections. As patients from whom C trachomatis antigens were detected by Chlamydiazmye were also included in the case group, however, we are confident that all current infections were found.
The manufacturer's instructions do not specify which serotype of C trachomatis was used to make the substrate slides. It is clear that the serotype antigen could affect the titre results.9 10 Furthermore, antinuclear antibodies may produce non-specific reac tions in the single antigen test for antibodies to C trachomatis. High levels of antinuclear antibodies present in some serum samples need to be differentiated from the fluorescence due to specific antibodies Whole inclusion serum testfor IgG antibody to C Trachomatis in asymptomatic women to C trachomatis to avoid false positive interpretations. Autoantibodies may also mask the detection of antibodies to C trachomatis. The manufacturer's directions fail to mention this problem or suggest methods to remove these autoantibodies, such as absorption with uninfected cells."
Reports from Scandinavia have indicated a high rate of pelvic inflammatory disease after termination of pregnancy in women 'with chlamydial infection.'2-' 6 We cannot therefore recommend the use of this antibody test as a replacement for isolation or detection ofantigen in patients considered for termination of pregnancy or in women previously infected with C trachomatis. Kordova et al also found that the presence of chlamydial antibodies as detected with Electro-Nucleonics' assay did not correlate with isolation results in patients from Manitoba, Canada, who had symptoms suggestive of genital chlamydial infections. ' 
